Home › Funds › ARGA Investment Management, LP › BMRN
ARGA Investment Management, LP position in BMRN
BIOMARIN PHARMACEUTICAL INC · Health Care
ARGA Investment Management, LP reported holding 737,541 shares of BMRN (BIOMARIN PHARMACEUTICAL INC) in its Q3 2026 13F filing — a position valued at US$44.3M, representing 1.12% of its reported portfolio and ranking #20 among its reported holdings. ARGA Investment Management, LP has disclosed BMRN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How ARGA Investment Management, LP's BMRN position evolved
ARGA Investment Management, LP first disclosed a stake in BMRN in Q2 2026 at 1,039,409 shares (US$59.5M). Across 2 filings, ARGA Investment Management, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 737,541 shares valued at US$44.3M — a reduction of -301,868 shares quarter over quarter.. Notable position changes include a 29% trim in Q3 2026 (shares fell 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.04M | $59.47M | New |
| Q3 2026 | 737.54K | $44.25M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BMRN and 13F data
BMRN (BIOMARIN PHARMACEUTICAL INC) is a Health Care company. 26 other funds we track also report a position in BMRN — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$899.3M), Viking Global Investors (US$435.8M), VIKING GLOBAL INVESTORS LP (US$435.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BMRN
- PRIMECAP MANAGEMENT CO/CA/ 14.99M sh · $899.34M · Q3 2026
- Viking Global Investors 7.62M sh · $435.82M · Q2 2026
- VIKING GLOBAL INVESTORS LP 7.62M sh · $435.82M · Q2 2026
- Vestal Point Capital, LP 6.03M sh · $344.75M · Q2 2026
- Deep Track Capital, LP 3.31M sh · $189.25M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 111.50M sh · $108.89M · Q2 2026
More on ARGA Investment Management, LP
FAQ
How long has ARGA Investment Management, LP held BMRN?
ARGA Investment Management, LP has disclosed BMRN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is ARGA Investment Management, LP's current position in BMRN?
As of Q3 2026, ARGA Investment Management, LP holds 737.54K shares of BMRN (BIOMARIN PHARMACEUTICAL INC), valued at $44.25M, representing 1.12% of its reported portfolio and ranking #20.
Has ARGA Investment Management, LP been buying or selling BMRN?
In the latest 13F filing (Q3 2026), ARGA Investment Management, LP reduced its position in BMRN.
Which other funds hold BMRN?
Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, Viking Global Investors, VIKING GLOBAL INVESTORS LP, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.